CT-002

N/A

Report date: 2022/11/25 17:57:20

Base Information

Drug NameCT-002

Drug Alias NameTAPA-pulsed dendritic cell vaccineAPA pulsed dendritic cell vaccineTAPA-pulsed DC vaccine,Tumour associated peptide antigen loaded DC vaccineTumour associated peptide antigen pulsed dendritic cell productTumour associated peptide antigen pulsed dendritic cell vaccine +[8]

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHematologic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKiromic Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKiromic Biopharma Inc

Active IndicationsN/A

Inactive IndicationsHematologic NeoplasmsNeoplasms

Other Information

ATC CodeN/A